AU648690B2 - Apoptosis regulator - Google Patents

Apoptosis regulator

Info

Publication number
AU648690B2
AU648690B2 AU22317/92A AU2231792A AU648690B2 AU 648690 B2 AU648690 B2 AU 648690B2 AU 22317/92 A AU22317/92 A AU 22317/92A AU 2231792 A AU2231792 A AU 2231792A AU 648690 B2 AU648690 B2 AU 648690B2
Authority
AU
Australia
Prior art keywords
apoptosis regulator
apoptosis
regulator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU22317/92A
Other languages
English (en)
Other versions
AU2231792A (en
Inventor
Masakazu Adachi
Koutoku Aihara
Seiji Akamatsu
Hiroyuki Ichikawa
Hitomi Mori
Satoru Nakai
Fumio Saito
Michiaki Tominaga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of AU2231792A publication Critical patent/AU2231792A/en
Application granted granted Critical
Publication of AU648690B2 publication Critical patent/AU648690B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU22317/92A 1991-07-03 1992-07-02 Apoptosis regulator Ceased AU648690B2 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
JP3-162587 1991-07-03
JP16258791 1991-07-03
JP3346992 1992-02-20
JP4-33469 1992-02-20
JP4571892 1992-03-03
JP4-45718 1992-03-03
JP10058592 1992-03-25
JP4-100585 1992-03-25
PCT/JP1992/000841 WO1993000902A1 (fr) 1991-07-03 1992-07-02 Regulateur d'apoptose

Publications (2)

Publication Number Publication Date
AU2231792A AU2231792A (en) 1993-02-11
AU648690B2 true AU648690B2 (en) 1994-04-28

Family

ID=27459795

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22317/92A Ceased AU648690B2 (en) 1991-07-03 1992-07-02 Apoptosis regulator

Country Status (11)

Country Link
US (5) US5672603A (show.php)
EP (1) EP0552373B1 (show.php)
KR (1) KR100196368B1 (show.php)
AU (1) AU648690B2 (show.php)
CA (1) CA2090876A1 (show.php)
DE (1) DE69230131T2 (show.php)
DK (1) DK0552373T3 (show.php)
ES (1) ES2138971T3 (show.php)
MX (1) MX9203950A (show.php)
TW (1) TW229157B (show.php)
WO (1) WO1993000902A1 (show.php)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004504A1 (fr) * 1992-08-19 1994-03-03 Otsuka Pharmaceutical Co., Ltd. Regulateur d'apoptose
EP0638311A4 (en) * 1993-03-02 1997-05-02 Otsuka Pharma Co Ltd REJECTION INHIBITOR FOR TRANSPLANTATIONS AND INTERLEUKIN PRODUCTION INHIBITOR 1.
GB9311132D0 (en) * 1993-05-28 1993-07-14 Eisai London Res Lab Ltd Control of cell death
KR100191191B1 (ko) * 1993-10-21 1999-06-15 오쓰까 아끼히꼬 인터루킨-8합성억제의 카르보스티릴 유도체
US5504093A (en) * 1994-08-01 1996-04-02 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting nucleoside and nucleobase transport in mammalian cells, and method for inhibition of DNA virus replication
MX9603868A (es) * 1995-01-11 1997-03-29 Otsuka Pharma Co Ltd Composicion farmaceutica de derivados de indeno para la regulacion de la apoptosis.
WO1998046229A1 (en) * 1995-06-21 1998-10-22 Otsuka Pharmaceutical Co., Ltd. Il-8 and mcaf production inhibitors
JPH0971532A (ja) * 1995-09-06 1997-03-18 Otsuka Pharmaceut Co Ltd 発癌抑制剤
US5700803A (en) * 1995-12-12 1997-12-23 Otsuka Pharmaceutical Co., Ltd. Method for reducing infarct size in subjects afflicted with ischemic heart disease
WO1998048807A1 (en) * 1997-04-25 1998-11-05 Otsuka Pharmaceutical Co., Ltd. Hyaluronate synthesis inhibitors
US6008209A (en) * 1997-04-28 1999-12-28 Hoffmann-La Roche Inc. Method of using vitamin D3 analogs with bis C-20 side chains
US6544972B1 (en) 1997-09-25 2003-04-08 Regents Of The University Of Minnesota Methods of limiting apoptosis of cells
US6281191B1 (en) 1997-12-29 2001-08-28 Vladimir I. Slesarev Compositions and methods for treating hepatitis-C
FR2774289B1 (fr) 1998-02-03 2002-05-24 Goemar Lab Sa Medicament pour le traitement des dereglements de l'apoptose
EP2311490A3 (en) 1998-07-13 2011-05-04 Board of Regents, The University of Texas System Uses of antibodies to aminophospholipids for cancer treatment
SI1107795T1 (en) 1998-09-04 2003-06-30 The Regents Of The University Of Michigan Thiomolybdate associated with at least one carbohydrate, and its use for preventing or treating diseases characterized by aberrant vascularization, such as cancer, wet type macular degeneration, rheumatoid arthritis
US6277974B1 (en) 1999-12-14 2001-08-21 Cogent Neuroscience, Inc. Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
US20030044413A1 (en) * 2000-08-15 2003-03-06 Regents Of The University Of Minnesota Methods of limiting apoptosis of cells
WO2003053222A2 (en) * 2001-12-20 2003-07-03 Cogent Neuroscience, Inc. Methods for treating conditions, disorders, or diseases involving cell death
NZ596825A (en) 2002-07-15 2013-06-28 Univ Texas Duramycin peptides and their use in imaging
JP2006510740A (ja) * 2002-11-07 2006-03-30 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 出血と関連した神経系障害を治療する方法
WO2008109433A2 (en) 2007-03-02 2008-09-12 The Cleveland Clinic Foundation Anti-angiogenic peptides
US20060204481A1 (en) * 2003-04-02 2006-09-14 Steer Clifford J Methods of promoting cell viability
DK1718283T3 (da) 2004-01-22 2013-04-22 Univ Miami Topisk co-enzyme Q10 formuleringer og fremgangsmåder for anvendelse.
US20080194531A1 (en) * 2005-02-10 2008-08-14 Steer Clifford J Methods for Treating Visual Disorders
EP2614837A1 (en) 2007-11-09 2013-07-17 Affitech Research AS Anti-VEGF antibody compositions and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5430184A (en) * 1977-08-10 1979-03-06 Otsuka Pharmaceut Co Ltd 3,4-dihydrocarbostyril derivative
JPS6038384B2 (ja) * 1978-03-24 1985-08-31 大塚製薬株式会社 チオセミカルバゾン誘導体
JPS5777676A (en) * 1980-10-31 1982-05-15 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS5793962A (en) * 1980-12-01 1982-06-11 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
JPS62135423A (ja) * 1985-12-09 1987-06-18 Otsuka Pharmaceut Co Ltd 低酸素症改善剤

Also Published As

Publication number Publication date
MX9203950A (es) 1993-05-01
HK1004469A1 (en) 1998-11-27
KR100196368B1 (ko) 1999-06-15
US5925640A (en) 1999-07-20
WO1993000902A1 (fr) 1993-01-21
DE69230131T2 (de) 2000-03-02
DK0552373T3 (da) 1999-12-27
US5872120A (en) 1999-02-16
EP0552373A4 (en) 1993-09-22
TW229157B (show.php) 1994-09-01
US5916890A (en) 1999-06-29
KR930702002A (ko) 1993-09-08
ES2138971T3 (es) 2000-02-01
DE69230131D1 (de) 1999-11-18
US5672603A (en) 1997-09-30
EP0552373A1 (en) 1993-07-28
EP0552373B1 (en) 1999-10-13
US5798358A (en) 1998-08-25
AU2231792A (en) 1993-02-11
CA2090876A1 (en) 1993-01-04

Similar Documents

Publication Publication Date Title
AU648690B2 (en) Apoptosis regulator
AU4761593A (en) Apoptosis regulator
AU6018194A (en) Easy intubator
HU9600083D0 (en) Regulated apoptosis
AU1590292A (en) Modified complement system regulator
AU655472B2 (en) Imidazodiazepines
AU653847B2 (en) Benzodioxanderivate
AU1319492A (en) Spectrophotometer
AU1782292A (en) Gridbeam
AU654362B2 (en) Pyrrolopyrazines
AU2636292A (en) Anti-alpha6-integrin-antibodies
AU2135292A (en) Cyanophenylpyrroles
AU1556892A (en) 2-substituted-2-imidazolines
AU1080292A (en) Ige-receptor-antibodies
AU2831692A (en) Novel expression system
AU1766292A (en) Ibuprofen-decongestant combinations
AU2010992A (en) Novel azabicyclobenzisoquinolines
AU2586192A (en) Imaginograph
AU1752492A (en) Diamino-alpha-alkylstilbenes
AU3018192A (en) Sulfonimidamides
AU647640B2 (en) Quinolin-2-yl-methoxybenzylhydroxyureas
AU1732692A (en) Substituted imidazolinylpyrimidines
AU2979992A (en) Quinolylmethoxyphenyl-acetamides
AU2521192A (en) Polyolefin-polyamine-N-substituted poly-carbamates
AU1669792A (en) Azabicycloheptanone

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired